Patent Application
20250120629
As techniques and methodologies for medical testing and diagnostics advance, more and more consumers are turning to remote sample collection using “at-home” test kits that may involve collecting a blood sample using a Dried Blood Spot (DBS) card having the means to collect, store, and ship blood samples from patients to remote diagnostics center for further testing and analysis. In a typical procedure, a patient will induce a blood flow from a finger by pricking the finger allowing blood to flow for enough time to drip onto a dedicated collection medium, such as a DBS card. As is known in the profession, DBS cards may have a typical form factor wherein a patient may deposit up to five blood samples, or more, in dedicated sample areas and then, after allowing time to dry, package the entire DBS card for mailing or transit to a remote testing facility. Results of testing or diagnostics may then be communicated to the patient using standard confidentiality protocols.
However, the standard DBS card form factor is prone to problems such as contamination or spoiled samples. That is, as the portion of the DBS card that collects the blood sample is open to human touching and foreign objects during the collection and transit procedures, the blood sample itself may be compromised to the point of causing unreliable testing results. Further, as the DBS card typically has five “spots” available for blood collection, often times, a typical finger prick may not provide enough blood to fill all five spots. This prompts the patient to collect from another finger after some time. If a blood collection spot dries before being completed or has additional samples to it after some drying has occurred, the entire sample may also be compromised. As is standard with self-collection test kits, collection should be prompt and distinct for each of the typical five spots in order to maximize the chances for proper and reliable testing and diagnostics. Thus, conventional open faced DBS cards are susceptible to opportunities for failure during blood collection and transit.
Embodiments of the subject matter disclosed herein in accordance with the present disclosure will be described with reference to the drawings, in which:
Note that the same numbers are used throughout the disclosure and figures to reference like components and features.
The subject matter of embodiments disclosed herein is described here with specificity to meet statutory requirements, but this description is not necessarily intended to limit the scope of the claims. The claimed subject matter may be embodied in other ways, may include different elements or steps, and may be used in conjunction with other existing or future technologies. This description should not be interpreted as implying any particular order or arrangement among or between various steps or elements except when the order of individual steps or arrangement of elements is explicitly described.
Embodiments will be described more fully hereinafter with reference to the accompanying drawings, which form a part hereof, and which show, by way of illustration, exemplary embodiments by which the devices described herein may be practiced. These devices may, however, be embodied in many different forms and should not be construed as limited to the embodiments set forth herein; rather, these embodiments are provided so that this disclosure will satisfy the statutory requirements and convey the scope of the subject matter to those skilled in the art.
By way of an overview, the systems and devices discussed herein may be directed to a device that assists with correct and efficient collection of capillary blood onto dried blood spot collection (DBS) card. This device may comprise a rectangular shape configured to hold a DBS card in a desired orientation for blood sample collection. The device comprises apertures on a top face that are aligned above the circular target spots on the encompassed DBS card. The patient will be able to direct drops of capillary blood to pass through the top apertures and then blood will travel into the DBS card at precise locations so as to ensure proper saturation while minimizing risk of outside contaminants and/or cross-contamination between target spots. Further, the patient can verify saturation level by looking through observation orifices disposed on the backside of the device.
This collection assistance device is an improvement to the collection because the device prevents the patient from rubbing a finger directly on the DBS card and prevents the patient from spotting blood on the wrong side of the DBS card. Further, the device promotes the capillary blood to be collected in manner that is centered on each target spot on the DBS card and additionally prevents for blood to be spotted in other areas of the DBS card. Further yet, the sides of the device have four ventilation openings which allow for more efficient drying. Internal components of the device include small legs throughout the inside of the device that hold the DBS card level and aligned with the collection apertures with minimal contact with the plastic device. The overall device also serves as a protective shield for the DBS card before collection, during collection, and after collection. These and other aspects of the subject matter disclosed herein are described below with respect to
Once dried, specimens may be stored in low gas-permeability plastic bags with desiccant added to reduce humidity, and may be kept at ambient temperature prior to, during, and after shipping. Once in the laboratory, technicians may separate a small disc of saturated paper (e.g., poke a hole) from the sheet using an automated or manual hole punch, dropping the separated disc into a flat-bottomed microtiter plate. The blood is eluted out from the separated disc into a phosphate buffered saline. The resultant plate containing the eluates forms the “master” from which dilutions can be made for subsequent testing.
In the embodiment shown in
The top portion 220 includes five apertures 214a-214e in a top face 223 for assisting in collecting capillary blood from a patient. In embodiments, each aperture comprises a conical opening with an upper diameter (e.g., in the plane of the top face 223) that is between 0.5 to 1.5 inches. The lower diameter is slightly less to provide a conical shape to each aperture 214a-214e. As will be discussed below, the bottom portion 221 also includes a bottom face (224 of
When mated, the top portion 220 and bottom portion 221 may exhibit a first elongate ventilation opening 227 along a first direction in two sides (only the one side is shown in
The device 200, as alluded to above, comprises five apertures 214a-214e on the top face 223 of the top portion 220 that are aligned above the circular target spots 104a-104e on the encompassed DBS card 100. When is use, a patient (not shown) will be able to direct drops of capillary blood to pass through the top side 223 such that blood will travel through the apertures 214a-214e to the DBS card 100 at precise locations so as to ensure proper saturation of each respective target spot 104e-104e while minimizing risk of outside contaminants and/or cross-contamination between target spots 104a-104e.
When mated, specific border portions 872 disposed on the insides of both the top portion 220 and the bottom portion may provide a guide for holding the DBS card 100 inside cavity 868 and aligned such that the target blood spots on the DBS card are disposed directly under a respective blood collection aperture 414a-414e and directly over a respective observation window (414a and 414b are shown here).
Additionally, the device 200 may include a desiccant card 890 disposed on the inside of one of the portions. The desiccant card 890 may be adhered to device 200 and aid in dry time but also prevent rejections when patients discard the desiccant pack in a specimen bag or when a kit is incorrectly built without a desiccant for the specimen bag. Having a desiccant may prevent user error and possibly prevent safety issues of a separate desiccant falling out specimen bag or bag such that a person may inadvertently ingest it.
Further yet, the device 200 may include a transparent film 875 disposed on the inside of the bottom portion between the observation windows 414a-414e and the cavity 868 for holding the DBS card 100. The transparent film 875 may be adhered to device 200 and aid in preventing contamination when collected blood soaks through the DBS card and comes into contact with undesired chemicals. Having a transparent film 875 may prevent user error during collection and observation and possibly prevent safety issues of excess blood escaping the collection device exposing others not wishing to be exposed.
In this view, the apertures 214a-214e can be seen from a directly overhead view revealing the conical nature of the apertures 214a-214e. Thus, as blood is passed through these apertures 214a-214e, the underlying DBS card 100 may be saturated with blood as needed for the collection procedure.
Further, in this view, front-facing observation windows 914a-914e can be seen from a directly overhead view of the topside revealing holes resembling crescent shapes of two halves of a circle. Each respective front-facing observation windows 914a-914e encircles a respective aperture 214a-214e. Thus, as blood is passed through the top face 223 apertures 214a-214e, the underlying DBS card 100 may be saturated with blood as needed for the collection procedure such that one can see the saturation of the DBS card 100 through the observation windows 914a-914e. This allows the patient to verify saturation level by looking through front-facing observation windows 914a-914e disposed on the top face 223 of the device 200 such that the patient does not need to flip the device 200 over to verify saturation levels. The front-facing observation windows 914a-914e may also include transparent window materials to prevent blood from entering the front-facing observation windows 914a-914e. This provides a way to observe through to the DBS card at the edges of the target spots 104a-104e but without risk of contamination through the front-facing observation windows 914a-914e.
In this view, the apertures 214a-214e can be seen from a directly overhead view revealing the conical nature of the apertures 214a-214e as well as the “W” pattern of alignment. Thus, as blood is passed through these apertures 214a-214e, the underlying DBS card 100 may be saturated with blood as needed for the collection procedure.
Further, in this view, front-facing observation windows 914a-914e can be seen from a directly overhead view of the topside 223 revealing holes resembling crescent shapes of two halves of a circle. Each respective front-facing observation windows 914a-914e encircles a respective aperture 214a-214e. Thus, as blood is passed through the top face 223 apertures 214a-214e, the underlying DBS card 100 may be saturated with blood as needed for the collection procedure such that one can see the saturation of the DBS card 100 through the observation windows 914a-914e. This allows the patient to verify saturation level by looking through front-facing observation windows 914a-914e disposed on the top face 223 of the device 200 such that the patient does not need to flip the device 200 over to verify saturation levels. The front-facing observation windows 914a-914e may also include transparent window materials to prevent blood from entering the front-facing observation windows 914a-914e. This provides a way to observe through to the DBS card at the edges of the target spots 104a-104e but without risk of contamination through the front-facing observation windows 914a-914e.
The use of the terms “a” and “an” and “the” and similar referents in the specification and in the following claims are to be construed to cover both the singular and the plural, unless otherwise indicated herein or clearly contradicted by context. The terms “having,” “including,” “containing” and similar referents in the specification and in the following claims are to be construed as open-ended terms (e.g., meaning “including, but not limited to,”) unless otherwise noted. Recitation of ranges of values herein are merely indented to serve as a shorthand method of referring individually to each separate value inclusively falling within the range, unless otherwise indicated herein, and each separate value is incorporated into the specification as if it were individually recited herein. All methods described herein can be performed in any suitable order unless otherwise indicated herein or clearly contradicted by context. The use of any and all examples, or exemplary language (e.g., “such as”) provided herein, is intended merely to better illuminate embodiments and does not pose a limitation to the scope of the disclosure unless otherwise claimed. No language in the specification should be construed as indicating any non-claimed element as essential to each embodiment of the present disclosure.
Different arrangements of the components depicted in the drawings or described above, as well as components and steps not shown or described are possible. Similarly, some features and sub-combinations are useful and may be employed without reference to other features and sub-combinations. Embodiments have been described for illustrative and not restrictive purposes, and alternative embodiments will become apparent to readers of this patent. Accordingly, the present subject matter is not limited to the embodiments described above or depicted in the drawings, and various embodiments and modifications can be made without departing from the scope of the claims below.
